PVI
ACER

Pura Vida Investments’s Acer Therapeutics Inc ACER Stock Holding History

Pura Vida Investments’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-41,795
Closed -$805K – 115
2018
Q1 		$805K Sell
41,795
-48,865
-54% -$896K 0.48% 51
2017
Q4 		$1.26M Buy
+90,660
New +$1.48M 0.53% 53

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Pura Vida Investments's ACER Position: Q2 2018 in Review

Pura Vida Investments sold out of Acer Therapeutics Inc (ACER) in Q2 2018, closing a stake of 41,795 shares — an estimated $805K sold.

Pura Vida Investments first reported a position in ACER in Q4 2017 and held it in 2 quarters. The position peaked at $1.26M in Q4 2017. 17 funds tracked by Wall St. Rank hold ACER as of Q2 2018.

  • Pura Vida Investments reported no remaining Acer Therapeutics Inc position as of Q2 2018 after selling out during the quarter.
  • Pura Vida Investments sold 41,795 Acer Therapeutics Inc shares in Q2 2018, an estimated $805K.
  • Pura Vida Investments first reported a position in Acer Therapeutics Inc in Q4 2017 and held it in 2 quarters.
  • Pura Vida Investments's Acer Therapeutics Inc position peaked at $1.26M in Q4 2017.
  • 17 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2018.

Based on Pura Vida Investments's 13F filing for Q2 2018, filed 14 Aug 2018.